Nano-X Imaging Ltd. has expanded its U.S. distribution network through a partnership with Radiology Oncology Systems (ROS) to distribute its Nanox.ARC systems. This FDA-cleared, multisource digital tomosynthesis technology offers 3D imaging capabilities at a lower cost and reduced radiation exposure compared to traditional CT systems. The collaboration aims to enhance access to advanced imaging solutions in oncology and adjacent care settings across the U.S., leveraging ROS’s established distribution network.

The significance of this partnership lies in the potential clinical impact of the Nanox.ARC system. By integrating advanced imaging technology with a focus on cost-effectiveness and safety, Nanox aims to facilitate earlier disease detection and improve patient outcomes. The deployment of Nanox.ARC systems, supported by ROS’s expertise in diagnostic imaging, is expected to enhance clinical efficiency and broaden access to preventive healthcare solutions, aligning with the ongoing shift towards integrated, preventive health strategies.

This agreement marks a pivotal moment in Nanox’s strategy to diversify its distribution channels, emphasizing the importance of partnerships in scaling innovative healthcare technologies. The collaboration not only accelerates the commercial rollout of the Nanox.ARC but also signals a broader trend in the imaging sector towards more accessible, AI-enhanced diagnostic tools. As the field moves towards preventive care, this partnership may influence future research and development timelines, potentially expediting the integration of advanced imaging technologies into routine clinical practice.

Source: globenewswire.com